nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HTR2C—metabolic syndrome X	0.74	1	CbGaD
Iloperidone—HTR7—sympathetic nervous system—metabolic syndrome X	0.00881	0.107	CbGeAlD
Iloperidone—HTR2A—arteriole—metabolic syndrome X	0.00862	0.105	CbGeAlD
Iloperidone—HTR7—autonomic nervous system—metabolic syndrome X	0.00592	0.0718	CbGeAlD
Iloperidone—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00549	0.0666	CbGeAlD
Iloperidone—HTR1D—artery—metabolic syndrome X	0.00421	0.0511	CbGeAlD
Iloperidone—HTR2A—autonomic nervous system—metabolic syndrome X	0.00369	0.0448	CbGeAlD
Iloperidone—Sinus congestion—Metformin—metabolic syndrome X	0.00337	0.103	CcSEcCtD
Iloperidone—HTR7—artery—metabolic syndrome X	0.00336	0.0407	CbGeAlD
Iloperidone—HTR1D—blood vessel—metabolic syndrome X	0.00328	0.0398	CbGeAlD
Iloperidone—HTR7—endothelium—metabolic syndrome X	0.00284	0.0344	CbGeAlD
Iloperidone—Paliperidone—HTR2C—metabolic syndrome X	0.00268	0.367	CrCbGaD
Iloperidone—HTR7—blood vessel—metabolic syndrome X	0.00261	0.0317	CbGeAlD
Iloperidone—HTR2A—artery—metabolic syndrome X	0.00209	0.0254	CbGeAlD
Iloperidone—Rhinorrhoea—Metformin—metabolic syndrome X	0.00207	0.0635	CcSEcCtD
Iloperidone—Cisapride—HTR2C—metabolic syndrome X	0.00203	0.278	CrCbGaD
Iloperidone—Blood disorder—Metformin—metabolic syndrome X	0.00201	0.0616	CcSEcCtD
Iloperidone—Risperidone—HTR2C—metabolic syndrome X	0.002	0.274	CrCbGaD
Iloperidone—HTR2A—endothelium—metabolic syndrome X	0.00177	0.0214	CbGeAlD
Iloperidone—HTR2A—blood vessel—metabolic syndrome X	0.00163	0.0198	CbGeAlD
Iloperidone—CYP3A7—liver—metabolic syndrome X	0.00158	0.0191	CbGeAlD
Iloperidone—HTR1D—cardiovascular system—metabolic syndrome X	0.00146	0.0178	CbGeAlD
Iloperidone—HTR1D—kidney—metabolic syndrome X	0.00143	0.0174	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.00134	0.0163	CbGeAlD
Iloperidone—Nasal congestion—Metformin—metabolic syndrome X	0.00134	0.041	CcSEcCtD
Iloperidone—Lethargy—Metformin—metabolic syndrome X	0.00124	0.0381	CcSEcCtD
Iloperidone—HTR1A—cardiovascular system—metabolic syndrome X	0.00122	0.0148	CbGeAlD
Iloperidone—SIGMAR1—adipose tissue—metabolic syndrome X	0.0012	0.0146	CbGeAlD
Iloperidone—HTR7—cardiovascular system—metabolic syndrome X	0.00117	0.0142	CbGeAlD
Iloperidone—HTR7—kidney—metabolic syndrome X	0.00114	0.0138	CbGeAlD
Iloperidone—Dehydration—Metformin—metabolic syndrome X	0.00113	0.0347	CcSEcCtD
Iloperidone—ADRA1A—cardiovascular system—metabolic syndrome X	0.00113	0.0136	CbGeAlD
Iloperidone—Breast disorder—Metformin—metabolic syndrome X	0.0011	0.0338	CcSEcCtD
Iloperidone—Nasopharyngitis—Metformin—metabolic syndrome X	0.00109	0.0334	CcSEcCtD
Iloperidone—ADRA2C—kidney—metabolic syndrome X	0.00105	0.0127	CbGeAlD
Iloperidone—Abdominal discomfort—Metformin—metabolic syndrome X	0.00101	0.031	CcSEcCtD
Iloperidone—ADRA1A—adipose tissue—metabolic syndrome X	0.000992	0.012	CbGeAlD
Iloperidone—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000978	0.03	CcSEcCtD
Iloperidone—ADRA2C—adipose tissue—metabolic syndrome X	0.000946	0.0115	CbGeAlD
Iloperidone—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000887	0.0272	CcSEcCtD
Iloperidone—CYP3A5—kidney—metabolic syndrome X	0.000878	0.0107	CbGeAlD
Iloperidone—SIGMAR1—liver—metabolic syndrome X	0.000844	0.0102	CbGeAlD
Iloperidone—CYP2E1—cardiovascular system—metabolic syndrome X	0.000837	0.0102	CbGeAlD
Iloperidone—Connective tissue disorder—Metformin—metabolic syndrome X	0.000827	0.0254	CcSEcCtD
Iloperidone—CYP2E1—kidney—metabolic syndrome X	0.000819	0.00993	CbGeAlD
Iloperidone—CYP3A5—adipose tissue—metabolic syndrome X	0.000791	0.0096	CbGeAlD
Iloperidone—Eye disorder—Metformin—metabolic syndrome X	0.000787	0.0242	CcSEcCtD
Iloperidone—Cardiac disorder—Metformin—metabolic syndrome X	0.000781	0.024	CcSEcCtD
Iloperidone—HRH1—adipose tissue—metabolic syndrome X	0.000768	0.00932	CbGeAlD
Iloperidone—Angiopathy—Metformin—metabolic syndrome X	0.000764	0.0234	CcSEcCtD
Iloperidone—Mediastinal disorder—Metformin—metabolic syndrome X	0.000759	0.0233	CcSEcCtD
Iloperidone—ADRA2A—adipose tissue—metabolic syndrome X	0.000754	0.00915	CbGeAlD
Iloperidone—Malnutrition—Metformin—metabolic syndrome X	0.000733	0.0225	CcSEcCtD
Iloperidone—HTR2A—cardiovascular system—metabolic syndrome X	0.000727	0.00882	CbGeAlD
Iloperidone—HTR7—liver—metabolic syndrome X	0.000721	0.00875	CbGeAlD
Iloperidone—HTR2A—kidney—metabolic syndrome X	0.000712	0.00863	CbGeAlD
Iloperidone—Muscle spasms—Metformin—metabolic syndrome X	0.000705	0.0216	CcSEcCtD
Iloperidone—ADRA1A—liver—metabolic syndrome X	0.000696	0.00844	CbGeAlD
Iloperidone—Vision blurred—Metformin—metabolic syndrome X	0.000691	0.0212	CcSEcCtD
Iloperidone—Tremor—Metformin—metabolic syndrome X	0.000687	0.0211	CcSEcCtD
Iloperidone—ADRA2C—liver—metabolic syndrome X	0.000663	0.00804	CbGeAlD
Iloperidone—CYP3A4—kidney—metabolic syndrome X	0.000659	0.00799	CbGeAlD
Iloperidone—CYP2D6—kidney—metabolic syndrome X	0.000648	0.00787	CbGeAlD
Iloperidone—Palpitations—Metformin—metabolic syndrome X	0.000648	0.0199	CcSEcCtD
Iloperidone—Myalgia—Metformin—metabolic syndrome X	0.000624	0.0192	CcSEcCtD
Iloperidone—Oedema—Metformin—metabolic syndrome X	0.000598	0.0184	CcSEcCtD
Iloperidone—Infection—Metformin—metabolic syndrome X	0.000594	0.0182	CcSEcCtD
Iloperidone—Gefitinib—ALB—metabolic syndrome X	0.000589	0.0806	CrCbGaD
Iloperidone—Nervous system disorder—Metformin—metabolic syndrome X	0.000587	0.018	CcSEcCtD
Iloperidone—CYP1A2—liver—metabolic syndrome X	0.000575	0.00698	CbGeAlD
Iloperidone—Hypotension—Metformin—metabolic syndrome X	0.000559	0.0172	CcSEcCtD
Iloperidone—CYP3A5—liver—metabolic syndrome X	0.000555	0.00673	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000545	0.0167	CcSEcCtD
Iloperidone—Paraesthesia—Metformin—metabolic syndrome X	0.000537	0.0165	CcSEcCtD
Iloperidone—Dyspnoea—Metformin—metabolic syndrome X	0.000533	0.0164	CcSEcCtD
Iloperidone—Somnolence—Metformin—metabolic syndrome X	0.000532	0.0163	CcSEcCtD
Iloperidone—CYP2E1—liver—metabolic syndrome X	0.000518	0.00628	CbGeAlD
Iloperidone—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000516	0.0159	CcSEcCtD
Iloperidone—Fatigue—Metformin—metabolic syndrome X	0.000516	0.0158	CcSEcCtD
Iloperidone—Feeling abnormal—Metformin—metabolic syndrome X	0.000493	0.0151	CcSEcCtD
Iloperidone—HTR2A—liver—metabolic syndrome X	0.00045	0.00546	CbGeAlD
Iloperidone—Asthenia—Metformin—metabolic syndrome X	0.000429	0.0132	CcSEcCtD
Iloperidone—CYP3A4—liver—metabolic syndrome X	0.000416	0.00505	CbGeAlD
Iloperidone—CYP2D6—liver—metabolic syndrome X	0.00041	0.00497	CbGeAlD
Iloperidone—Diarrhoea—Metformin—metabolic syndrome X	0.000409	0.0126	CcSEcCtD
Iloperidone—Dizziness—Metformin—metabolic syndrome X	0.000396	0.0121	CcSEcCtD
Iloperidone—Rash—Metformin—metabolic syndrome X	0.000377	0.0116	CcSEcCtD
Iloperidone—Dermatitis—Metformin—metabolic syndrome X	0.000377	0.0116	CcSEcCtD
Iloperidone—Nausea—Metformin—metabolic syndrome X	0.000355	0.0109	CcSEcCtD
Iloperidone—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.33e-05	9.64e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.33e-05	9.63e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.32e-05	9.58e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—NOS3—metabolic syndrome X	1.32e-05	9.55e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.32e-05	9.54e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.31e-05	9.49e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.31e-05	9.46e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.31e-05	9.46e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	9.43e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AGT—metabolic syndrome X	1.3e-05	9.42e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	9.41e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AGT—metabolic syndrome X	1.3e-05	9.4e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.3e-05	9.39e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.3e-05	9.39e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.3e-05	9.39e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	1.29e-05	9.32e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	9.28e-05	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—AKT1—metabolic syndrome X	1.28e-05	9.27e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.28e-05	9.27e-05	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—AKT1—metabolic syndrome X	1.28e-05	9.26e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.28e-05	9.24e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.28e-05	9.24e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.27e-05	9.23e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.27e-05	9.23e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—APOE—metabolic syndrome X	1.27e-05	9.23e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.27e-05	9.22e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.27e-05	9.22e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—APOE—metabolic syndrome X	1.27e-05	9.21e-05	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.27e-05	9.2e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.27e-05	9.19e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.26e-05	9.13e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	9.13e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	1.26e-05	9.13e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—APOA1—metabolic syndrome X	1.26e-05	9.12e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	1.26e-05	9.12e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	9.11e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—APOA1—metabolic syndrome X	1.26e-05	9.1e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.25e-05	9.09e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.25e-05	9.06e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	9.04e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	9.04e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.24e-05	8.99e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.23e-05	8.94e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.23e-05	8.94e-05	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.22e-05	8.87e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.22e-05	8.84e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.22e-05	8.84e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.21e-05	8.79e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.21e-05	8.75e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	1.21e-05	8.73e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.21e-05	8.73e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.2e-05	8.7e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—INS—metabolic syndrome X	1.19e-05	8.59e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.18e-05	8.58e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.18e-05	8.55e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.18e-05	8.54e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.18e-05	8.54e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.17e-05	8.48e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.16e-05	8.43e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.16e-05	8.43e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.16e-05	8.42e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	1.16e-05	8.42e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	1.16e-05	8.41e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.16e-05	8.4e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.16e-05	8.4e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	8.39e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.16e-05	8.37e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.16e-05	8.37e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.16e-05	8.37e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.15e-05	8.36e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.15e-05	8.35e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.15e-05	8.32e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.15e-05	8.31e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	8.24e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	8.22e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.13e-05	8.18e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.13e-05	8.17e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.13e-05	8.17e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.12e-05	8.12e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.12e-05	8.08e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.11e-05	8.07e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.11e-05	8.05e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PPARG—metabolic syndrome X	1.11e-05	8.04e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PPARG—metabolic syndrome X	1.11e-05	8.02e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.11e-05	8.02e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	8.01e-05	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.1e-05	7.98e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.1e-05	7.97e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.1e-05	7.96e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	7.89e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	7.89e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—INS—metabolic syndrome X	1.09e-05	7.88e-05	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.09e-05	7.88e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	7.87e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.09e-05	7.87e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—INS—metabolic syndrome X	1.09e-05	7.87e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	1.08e-05	7.86e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.08e-05	7.81e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	7.76e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	7.76e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.07e-05	7.75e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.07e-05	7.75e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	7.75e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.07e-05	7.73e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	7.73e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	7.63e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	7.62e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	7.6e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.04e-05	7.53e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.04e-05	7.51e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.04e-05	7.5e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.03e-05	7.47e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.03e-05	7.42e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	7.37e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.01e-05	7.3e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.01e-05	7.3e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	1e-05	7.25e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1e-05	7.25e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.99e-06	7.23e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—metabolic syndrome X	9.98e-06	7.23e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—metabolic syndrome X	9.96e-06	7.21e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	9.91e-06	7.18e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	9.88e-06	7.16e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	9.88e-06	7.15e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	9.87e-06	7.15e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.81e-06	7.1e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.8e-06	7.1e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.75e-06	7.06e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	9.71e-06	7.03e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.59e-06	6.94e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOB—metabolic syndrome X	9.57e-06	6.93e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.56e-06	6.92e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—NOS3—metabolic syndrome X	9.55e-06	6.91e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	9.53e-06	6.91e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.53e-06	6.9e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—NOS3—metabolic syndrome X	9.53e-06	6.9e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.51e-06	6.89e-05	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.48e-06	6.86e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	9.45e-06	6.84e-05	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.43e-06	6.83e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	9.36e-06	6.78e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	9.33e-06	6.76e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	9.31e-06	6.74e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.28e-06	6.72e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.23e-06	6.68e-05	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.17e-06	6.64e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—LPL—metabolic syndrome X	9.14e-06	6.62e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.11e-06	6.59e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.04e-06	6.55e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	9.03e-06	6.54e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	8.99e-06	6.51e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	8.99e-06	6.51e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOA1—metabolic syndrome X	8.94e-06	6.47e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—metabolic syndrome X	8.73e-06	6.32e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	8.71e-06	6.31e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.71e-06	6.3e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.71e-06	6.3e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.69e-06	6.3e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CD36—metabolic syndrome X	8.68e-06	6.29e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.61e-06	6.23e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.56e-06	6.2e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	8.51e-06	6.16e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	8.39e-06	6.08e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.33e-06	6.03e-05	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.32e-06	6.03e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.19e-06	5.93e-05	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.19e-06	5.93e-05	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.17e-06	5.92e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARA—metabolic syndrome X	8.07e-06	5.85e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.06e-06	5.84e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	8.04e-06	5.82e-05	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.02e-06	5.81e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.89e-06	5.72e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.88e-06	5.7e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGT—metabolic syndrome X	7.82e-06	5.66e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—INS—metabolic syndrome X	7.73e-06	5.59e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOE—metabolic syndrome X	7.66e-06	5.55e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOA1—metabolic syndrome X	7.57e-06	5.48e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	7.56e-06	5.47e-05	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.45e-06	5.4e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—metabolic syndrome X	7.45e-06	5.39e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—metabolic syndrome X	7.44e-06	5.39e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.44e-06	5.39e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	7.42e-06	5.37e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	7.39e-06	5.35e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.39e-06	5.35e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.33e-06	5.31e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.31e-06	5.3e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.28e-06	5.27e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.28e-06	5.27e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.19e-06	5.2e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—metabolic syndrome X	7.12e-06	5.16e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.08e-06	5.13e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.08e-06	5.13e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.05e-06	5.11e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	6.87e-06	4.97e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	6.86e-06	4.97e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	6.82e-06	4.94e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.77e-06	4.91e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.76e-06	4.9e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.7e-06	4.85e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARG—metabolic syndrome X	6.67e-06	4.83e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	6.57e-06	4.76e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—INS—metabolic syndrome X	6.54e-06	4.74e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.42e-06	4.65e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—metabolic syndrome X	6.41e-06	4.64e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.32e-06	4.58e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.32e-06	4.58e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.3e-06	4.57e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.23e-06	4.51e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.2e-06	4.49e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.19e-06	4.48e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—metabolic syndrome X	6.06e-06	4.39e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.03e-06	4.37e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—metabolic syndrome X	6e-06	4.35e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	5.91e-06	4.28e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.91e-06	4.28e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.88e-06	4.26e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.84e-06	4.23e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	5.83e-06	4.23e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.75e-06	4.16e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—NOS3—metabolic syndrome X	5.74e-06	4.16e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.51e-06	3.99e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.48e-06	3.97e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	5.33e-06	3.86e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	5.25e-06	3.8e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.15e-06	3.73e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.08e-06	3.68e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.06e-06	3.66e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—INS—metabolic syndrome X	5.05e-06	3.66e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.92e-06	3.56e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.84e-06	3.5e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.78e-06	3.46e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.76e-06	3.45e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.75e-06	3.44e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.66e-06	3.38e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.63e-06	3.35e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.46e-06	3.23e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.43e-06	3.21e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.39e-06	3.18e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—metabolic syndrome X	4.39e-06	3.18e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.38e-06	3.17e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—metabolic syndrome X	4.38e-06	3.17e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.33e-06	3.14e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.3e-06	3.11e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.05e-06	2.93e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4e-06	2.89e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.11e-06	2.26e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.64e-06	1.91e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.04e-06	1.47e-05	CbGpPWpGaD
